1 day Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily
The Food and Drug Administration signed off on Vertex Pharmaceuticals’ next-generation triple drug for cystic fibrosis late Friday.
The post Vertex Wins An Early Approval; Why It Might Not Move Vertex's Beleaguered Stock appeared first on Investor…
Pharmaceuticals · Vertex (VRTX)
X